Persistence of Immune Response After Vaccination With MCC

Clinical trial NCT00310687 · COMPLETED

Trial details

NCT number: NCT00310687
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prevention of Meningococcal Infection

Start date: 2004-10-01
Primary completion: 2005-12-01
Enrollment: 1244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.